Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis

Volume: 21, Issue: 3, Pages: 379 - 388
Published: Mar 26, 2021
Abstract
Human Cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) are endowed with the ability of establishing lifelong latency in human hosts and reactivating in immunocompromised subjects, including patients suffering from ulcerative colitis (UC). We, therefore, aimed to investigate virus-specific immunity in UC patients. A cohort of 24 UC patients (14 responders and 10 refractory to therapy) and 26 control subjects was prospectively enrolled to...
Paper Details
Title
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis
Published Date
Mar 26, 2021
Volume
21
Issue
3
Pages
379 - 388
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.